The Delaware Department of Health and Social Services (DHSS) is seeking a qualified vendor to deliver a full continuum of substance‑use‑disorder (SUD) treatment services for uninsured and under‑insured adults (18+) across the state. The contract covers a 24‑month base period (with up to three optional one‑year renewals) and requires the provider to offer any combination of ASAM‑defined levels of care, from outpatient counseling to intensive inpatient withdrawal management, including medication‑assisted treatment, telehealth, and culturally competent, trauma‑informed care. Vendors must be licensed under Delaware’s Substance Abuse Facility Licensing Standards, carry specified insurance, and submit detailed budgets, monthly usage reports, and quarterly subcontractor reports. The solicitation is posted on Bonfire/Euna Procurement, with a non‑mandatory pre‑bid meeting on 12 Feb 2026, questions due 12 Jan 2026, and proposals due 26 Mar 2026.
• Scope: inpatient (Level 3.7, Level 3.7 WM), residential, partial‑hospitalization, intensive outpatient, outpatient, and peer‑support services.
• Required deliverables: individualized care plans, 24/7 crisis response, naloxone distribution, data reporting (GPRA, CRF, usage), and integration with DSAMH’s referral network.
• Evaluation: scored criteria (125 points) plus optional bonus points; pricing evaluated on a 10‑point scale using state‑published reimbursement rates.